Breast imaging is a representation
or reproduction of a breasts form. It is used in diagnosis of breast-related
abnormalities such as blocked milk ducts, fibrocystic breast changes,
intraductal papillomas, fibroadenomas, cysts and others. The technology is used
by physicians and oncology surgeons in order to perform diagnostis of breast
structure, lumps, cells composition and other internal parts of the breast. It
includes several technologies and tools for detection, screening, and diagnosis
of breast cancer. It is classified as invasive ductal carcinoma, metastatic
breast cancer, ductal carcinoma in situ, and inflammatory breast cancer.
According to study, “Global
Breast Imaging Market Size study, by technology (ionizing and
non-ionizing) and Regional Forecasts 2018-2025” the key companies operating in
the global breast imaging market are SonoCine, Inc., Fujifilm Holdings
Corporation, Siemens Healthcare, GE Healthcare, Aurora Imaging Technology,
Inc., Dilon Technologies, Inc., Philips Healthcare, Hologic, Inc., Gamma
Medical Merate S.P.A., CMR Naviscan Corp., Canon Inc., Koninklijke Philips NV.,
DUNE Medical Devices, Agfa-Gevaert Group.
Based on technology type, breast
imaging market is segmented into ionizing technologies, non-ionizing
technologies and other breast imaging technologies (electric impedance
tomography, Cone-beam Computed Tomography (CBCT) and optical imaging). Ionizing
technologies are further sub-segmented into full-field digital mammography,
analog mammography, Positron Emission Mammography (PEM), electric impedance
tomography, 3D breast tomosynthesis, Molecular Breast Imaging
(MBI)/Breast-Specific Gamma (BSGI) and positron emission tomography &
computed tomography (PET-CT). 3D tomosynthesis segment is projected to witness
highest growth rate owing to its benefits such as higher diagnostics accuracy
as compared to other technologies and improved efficiency during the forecast
period. Additionally, non-ionizing technologies are further sub-segmented into
breast MRI, optical imaging, breast thermography, breast ultrasound, and
automated whole-breast ultrasound (AWBU). In addition, based on end-user,
market is segmented into hospitals, ambulatory clinics, women’s health center,
and breast care clinics.
The breast imaging market is driven
by rise in awareness on early detection of breast cancer, followed by increase
in aging population, rise in advanced systems for efficient testing &
treatment of breast cancer, increase in standard of living and growth in
public-private investments, funds, and grants. However, unfavorable
reimbursement scenario, side effects of chemo and high cost of breast imaging
systems may impact the market. Moreover, miniaturization & technological
advancements in breast imaging technologies is a key opportunity for market.
Based on geography, the
North-American region dominates the breast imaging market owing to increase in
prevalence of breast cancer, unhealthy life style and rise in government
initiatives to promote precision medicine in the region. The European and
North-American regions are likely to emerge as the fastest growing regions in
terms of market share due to increase in investments in healthcare sector and
rise in awareness of breast cancer & related issues over the forecast
period. In upcoming years, it is expected that future of the market will be
bright caused by improvement in healthcare infrastructure, increase in research
& development (R&D) for breast cancer, rise in medical tourism, growth
in alcohol consumption and rise in geriatric population & increase in per
capita income during the forecast period. It is estimated that the market will
be reached at US $8.3 billion by 2025.
For more information, click on the
link below:
Related
Reports:-
Contact Us:
Ken Research
Ankur Gupta, Head Marketing &
Communications
+91
9015378249